On March 18, Well Lead Medical Co.Ltd(603309) announced that the registration certificate of three types of medical devices of bactiguard AB (hereinafter referred to as “bactiguard AB”) a disposable sterile catheter (hereinafter referred to as “BiP catheter”) of Sweden bactiguard Co., Ltd. (hereinafter referred to as “bactiguard AB”), which is the sole agent of the company, was recently approved by the State Drug Administration.
According to the official website of the State Food and drug administration, up to now, BiP catheter is the only antibacterial catheter in China that has obtained the registration certificate of class III medical devices. BiP catheter is a special Super slippery antibacterial indwelling catheter developed and produced by baikede company in Sweden. Its surface contains gold silver palladium alloy coating and hydrophilic coating. BIP catheter specific coating can prevent bacterial adhesion and growth by releasing micro current. It can reduce the adhesion and growth of bacteria, block the infection pathway, and reduce the friction on the surface of the catheter with hydrogels. The retention time in vivo can be up to 30 days. Survey data show that urinary tract infection accounts for 20.8% – 31.7% of nosocomial infection, second only to respiratory tract infection. A number of studies have shown that the use of BiP catheter can effectively prevent nosocomial infection, reduce the use of antibiotics and reduce medical costs. At present, coated catheters have been widely used in the United States and Europe, with a total sales of more than 100 million in the United States, Europe, Japan, China, Brazil, India and Mexico.
In recent years, Well Lead Medical Co.Ltd(603309) vigorously expanded the Chinese market and deepened the reform of sales model in view of the normalization trend of centralized procurement. All product business divisions in China have established strong professional terminal sales teams. Innovative products are also on the market, such as visual bronchial intubation, stone removal sheath and so on. The non-public offering plan previously completed by the company, the production and construction project of disposable alloy coated anti infective catheter is one of the raised investment projects. With the approval of BiP catheter and the promotion of raised investment project, the company will further enhance its competitive advantage in the field of catheterization and promote the upgrading of catheterization products.
